SlideShare una empresa de Scribd logo
1 de 81
Syncope …

         The Right Test for
         the Right Patient




(Osama Alhadramy MD, FRCP(C
   *
       Engel GL. 7th century
Objectives

   Who should be admitted?

   Who should admit/see the patient in the
    ER ?(getting the right consult(

   What is the right test for your patient?

   Cases
   76y M with high lipids ,HTN (HCT 4 /12(
   Recurrent exersional syncope q 4 days for 2/12
   Seen by GP , D/C HCT for postural hypotension
    without improvement .
   Exersional SOB for 2 y class I-III
   Nausea and Diarrhea for 2 weeks
   Multiple injuries
   O/E Obese , no CHF, no murmer
   84 y M with no health issues
   First episode witnessed syncope
   Minimal CP on exertion for months
   O/E B9, no murmurs
   -ve CK / Trop
?Are we doing good job




 WHO**
Statistical Information System**
Definition

     Syncope is a transient loss of
      consciousness, associated with loss of
      postural tone, with :
1.    spontaneous return to baseline
      neurologic function
2.    requiring no resuscitative efforts .


*AHA/ACCF Scientific Statement on the Evaluation of Syncope
J Am Coll Cardiol 2006;47:473– 84.
*EHA statement 2004
Impact of Syncope

                             100%

                                        73% 1          71% 2
                             80%
    Proportion of Patients




                                                                    60% 2
                             60%
                                                                                 37% 2
                             40%

                             20%

                              0%
                                     Anxiety/    Alter Daily   Restricted    Change
                                    Depression   Activities     Driving     Employment



Linzer, J Clin Epidemiol, 1991.
1

Linzer, J Gen Int Med, 1994.
2
Syncope: Etiology

                                                                Structural        Non-
     Neurally-                                   Cardiac
                               Orthostatic                       Cardio-         Cardio-
     Mediated                                   Arrhythmia
                                                                Pulmonary       vascular

          1                            2              3                4               5
   • Vasovagal               • Drug             • Brady         • Aortic       • Psychogenic
   • Carotid                   Induced            Sick sinus     Stenosis
                                                  AV block                    • Metabolic
     Sinus                   • ANS                              • HOCM
                                                • Tachy                          e.g. hyper-
   • Situational               Failure                          • Pulmonary
       Cough                    Primary          VT*                          ventilation
                                                  SVT          Hypertension
       Post-                    Secondary
                                                • Long QT       • PE
        micturition
                                                  Syndrome




                                              Unknown Cause
DG Benditt, UM Cardiac Arrhythmia Center
Neurally Mediated Syncope
Definitions




          EHA executive statement
          EHJ (2004( 25, 2054–2072
Famous MCQ in medicine

 …….. is the best tool to diagnose syncope
  and to determine the etiology .
EPS

History /Physical
ILR
HM
Telemetry
King's of Heart
CT
EEG
How good is H/P




    15 June 1997 • Annals of Internal Medicine
Clues in history
Associated symptoms
    Neurally-mediated syncope:
1.    Absence of cardiac disease
2.    Long history of syncope
       (Chronic presentation(
3.    After unpleasant sight, sound, smell or pain
4.    Prolonged standing or crowded, hot places
5.    Nausea, vomiting associated with syncope
6.    With head rotation, pressure on carotid sinus
     (as in tumors, shaving, tight collars(
    Syncope due to orthostatic hypotension:
1.   After standing up
2.   Temporal relationship with start of
     medication leading to hypotension or
     changes of dosage
3.   Presence of autonomic neuropathy or
     Parkinsonism
Things suggestive of seizure
   Prodrome (aura)
   Episode of abrupt onset associated with injury
   Presence of a tonic phase before the onset of rhythmic clonic
    activity
   Head deviation or unusual posturing during the episode
   Tongue biting (particularly involving the lateral aspect of the
    tongue)
   Loss of bladder or bowel control
   Prolonged postictal phase during which the patient is confused
    and disoriented.

                                     .J Am Coll Cardiol 2002 Jul 3;40(1):142-8
Are there predictors for
   ?cardiac syncope
Predictors of cardiac syncope
          all comers




           Am J Med 2001 Aug 15;111(3(:177-84
Predictors in patients with SHD




    JACC Vol. 37, No. 7, 2001 June 1,2001:1921– 8
Patients without SHD




JACC Vol. 37, No. 7, 2001 June 1, 2001:1921–8
Absence of Pre-syncope

   The sudden loss of consciousness without
    warning (pre-syncope( is most likely to
    result from an arrhythmia (bradycardia or
    tachycardia(.
American Heart Journal 818 Krahn et al May 2001
Duration of symptoms

    A prolonged loss of consciousness may
    indicate a seizure or aortic stenosis.
   By comparison, arrhythmias and
    neurocardiogenic syncope are often
    associated with a brief period of syncope,
    since the supine position reestablishes
    some blood flow to the brain and can
    therefore result in the restoration of
    consciousness
Recovery

    Persistence of nausea, pallor, and
    diaphoresis in addition to a prolonged
    recovery from the episode suggest a vagal
    event.
   Significant neurologic changes or
    confusion during the recovery period may
    be due to a stroke or seizure.
PHYSICAL EXAMINATION

   Postural hypotension
   Irregular heart beats : AF
   Tachypnea : Massive PE
   Murmur
   CNS
   Rectal exam
work up

   Carotid sinus massage
   ECG
   Holter Monitor
   Implantable loop recorder
   Echocardiography
   Stress testing and angiogram
   Electrophysiological study

*ACC/AHA 2006
Carotid sinus massage


Class I in
patients above
the age of 40
ECG

   yield 2-10% *
   Not classified but class I (my guidelines(




* Kapoor, Am J Med, 1991.
Telemetry

    Class I
1.   For patient with structural heart disease
2.   High risk of life threatening arrhythmias.
Holter monitor

Yield 2-10%




                                                        Holter Monitor




                15 June 1997 • Annals of Internal Medicine
Holter Monitor

    Class I

1.   patients who have the clinical or ECG
     features suggesting an arrhythmic cause
     of syncope.

2.   Patients with very frequent syncopes
?Is one HM enough
    Series of 95 patients with syncope
1.   1st HM 14/95 (15%(
2.   2nd HM 9/ 81 (11%(
3.   3rd HM 3 /72 (4.2%(




                         Arch Intern Med. 1990 May;150(5):1073-8
Predictors of abnormal HM

1.   age above 65 years
2.   history of heart disease
3.   initial none sinus rhythm




                         Arch Intern Med. 1990 May;150(5):1073-8
(Event recorders (King's of heart

    Yield 20% *

    often do not provide useful information
     since the patient must be conscious in
     order to activate the unit and "store" the
     rhythm at the time of the symptom .




    .Krahn, Cardiology Clinics, 1997*
Implantable loop recorder

   Yield 65-90% **
   (ILR( is a subcutaneous monitoring device
    for the detection of cardiac arrhythmias.
    It stores recorded ECG strips either when
    the device is activated automatically
    according to programmed criteria or when
    the patient manually activates it with
    magnet application

                                    Krahn, Circulation, 1995*
                              Krahn, Cardiology Clinics, 1997*
Insertable Loop Recorder




Patient Activator   Reveal® Plus ILR   Programmer
56 y woman with syncope
 accompanied with seizures.
 AV Block




65 yo man with syncope.
VT and VF
RAST trial

                                      Unexplained Syncope
                                                              n=60


                         ILR                                             Conventional
                       n=30                                                    n=30



In Follow-up                 Diagnosed                   Undiagnosed   Diagnosed      Undiagnosed
     n=3                          n=14                        n=13       n=6             n=24

  Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
RAST Crossover Results

                                       Unexplained Syncope
                                                             n=60

                              13/30                                                    24/30
      Undiagnosed after monitoring                                       Undiagnosed after conventional
 6 accepted crossover to conventional                                     21 accepted crossover to ILR




Diagnosed               Undiagnosed                          Diagnosed       Undiagnosed       In follow-up
   n=1                           n=5                           n=8               n=5               n=8

 Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
RAST - Diagnoses
                     14

                     12
number of patients




                     10
                                                           ILR   Conventional
                     8

                     6

                     4

                     2

                     0
                          Bradycardia              Tachycardia    Vasovagal     Seizures
   Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
    Class I
1.   When the mechanism of syncope
     remains unclear after conventional work
     up.
2.   Patients who have the clinical or ECG
     features suggesting an arrhythmic
     syncope
3.   History of recurrent syncope with injury.
Are there patients who do
  not need any cardiac
        ?monitor
No need for any monitoring

    Class III (ECG monitoring is unlikely to
     be useful( :
1.   Do not have the clinical or ECG features
     suggesting an arrhythmic or structural
     heart disease
2.   No recurrent syncope( single episode(
Can they exclude cardiac causes of
            ?syncope
   Class I

    ECG monitoring excludes an arrhythmic
    cause when there is a correlation between
    syncope and no rhythm variation
Echocardiography

   Diagnoses of underlying structural heart
    disease such as left ventricular
    dysfunction, hypertrophic cardiomyopathy,
    or significant aortic stenosis .
   Yield 0-20%
Heart. 2002 Oct;88(4(:363-7.
   CONCLUSIONS:
    Echocardiography was most useful for
    assessing the severity of the underlying
    cardiac disease and for risk stratification in
    patients with unexplained syncope but
    with a positive cardiac history or an
    abnormal ECG
   Class I
   ECHO is recommended if suspect
    structural or coronary heart disease.
Upright tilt table test

       Very useful in young, and healthy patients
        in whom the diagnosis of
        neurocardiogenic syncope is suspected .
       Yield 11-90% ***




*PACE, Vol. 20 April 1997, Part I 875
*Kapoor, JAMA, 1992
Diagnosing VVS


(ACC Consensus Protocol(
   Overnight fast
   ECG
   Blood pressure
   Supine least 5 -20 min
   Tilt minimum of 20 min and a      60° 80°
    maximum of 45 min
PACE, Vol. 20 April 1997, Part I 875
    Class I
1.   Unexplained single syncopal episodes in
     high risk settings
2.   Recurrent episodes in the absence of
     organic heart disease
3.   In the presence of organic heart disease,
     after cardiac causes of syncope have
     been excluded.
Coronary angiogram / stress testing

    Class I
1.   In patients with syncope suspected to be
     due to myocardial ischemia.
2.   Patients with syncope and risk factors for
     CAD and symptoms of angina or angina
     equivalent.
3.   Syncope related to exersice
Electrophysiology study

     Patients who may benefit from an EP
      study include those with:
1.    Left ventricular dysfunction
2.    Significant coronary artery disease
3.    A prior myocardial infarction
4.    Other structural heart disease
5.    Conduction system disease (eg, bundle
      branch block(
     Yield 50%
 Stetson P, et al. PACE. 1999; 22 (part II): 782
    Class I
1.   Abnormal electrocardiography
2.   Structural heart disease
3.   syncope associated with palpitations or
     family history of sudden death
Can EPS role out cardiac causes of
           ??syncope
Class I
Normal electrophysiological findings can not
 completely exclude an arrhythmic cause of
                 syncope.
?What to do then
:Further work up

(ILR (preferred
     HM
King's of heart
BNP
148 patients with syncope




  THE AMERICAN JOURNAL OF CARDIOLOGY VOL. 93 JANUARY 15, 2004
?Who should be admitted

   Abnormal ECG
   History of cardiac disease, chest pain or heart
    failure
   Persistently low blood pressure (systolic <90
    mmHg(
   Exersional SOB or angina
   Hematocrit <30 (if obtained(
   Older age >60
   Family history of sudden cardiac death

                          Ann Emerg Med. 2007 Apr;49(4):431-44
                          Am J Emerg Med. 2005 Oct;23(6):782-6
?Why should we care
Prognosis




N Engl J Med, Vol. 347, No. 12 September 19, 2002
.AHA/ACC 2006 ©
Conventional Diagnostic Methods/Yield
                                   Test/Procedure                                                                                   Yield


         History and Physical                                                                                                   49-85% 1, 2
              (including carotid sinus massage(
         ECG                                                                                                                      2-11% 2

         Electrophysiology Study without SHD*                                                                                       11% 3

         Electrophysiology Study with SHD                                                                                           49% 3

         Tilt Table Test (without SHD)                                                                                          11-87% 4, 5

         Ambulatory ECG Monitors:
         •           Holter                                                                                                          2%       7



         •           External Loop Recorder                                                                                         20% 7
                      (2-3 weeks duration(
         •           Insertable Loop Recorder                                                                                   65-88% 6, 7
                       (up to 14 months duration(
         Neurological †
                (Head CT Scan, Carotid Doppler(                                                                                 0-4% 4,5,8,9,10

1
    Kapoor, et al N Eng J Med, 1983.     5
                                             Kapoor, JAMA, 1992                                9
                                                                                                   Day S, et al. Am J Med. 1982; 73: 15-23.
2
    Kapoor, Am J Med, 1991.              6
                                             Krahn, Circulation, 1995                          10
                                                                                                    Stetson P, et al. PACE. 1999; 22 (part II(: 782.   *   Structural Heart Disease
3
    Linzer, et al. Ann Int. Med, 1997.   7
                                             Krahn, Cardiology Clinics, 1997.
                                         8
                                             Eagle K,, et al. The Yale J Biol and Medicine. 1983; 56: 1-8.
                                                                                                                                                       †
                                                                                                                                                           MRI not studied
4
    Kapoor, Medicine, 1990.
Bottom line

    In young patients without suspicion of
    heart or neurological disease and
    recurrent syncope , tilt testing should be
    done first.
   Older patients, carotid sinus massage is
    recommended as first step.
   Patients with evidence of structural heart
    disease from H&P , palpitation,
    extensional symptoms cardiac work up
    should be done first .
..Back to the cases
   76y M with high lipids ,HTN (HCT 4 /12(
   Recurrent syncope q 4 days for 2/12
   Seen by GP , D/C HCT for postural
    hypotension without improvement .
   Exersional SOB for 2 y class II
   Nausea and Diarrhea for 2 weeks
   Multiple injuries
   O/E Obese , no CHF, no murmer
   Telemetry : no arrhythmia
   ECHO:EF 40% with segmental RWMA,
    mild AV sclerosis
   MIBI: High risk Circ ischemia , EF 45%
   84 y M with no health issues
   First episode witnessed syncope
   Minimal CP on exertion for months
   O/E B9, no murmurs
   -ve CK / Trop
   EP : Pace maker
   ECHO: EF 45-50% with DD
   D/C home
   10 days later came with syncope / fall
   New ant T changes with Trop 23 , no CP
Thanks

Más contenido relacionado

La actualidad más candente (20)

Fainting: Causes and Ways to Minimize Risk
Fainting: Causes and Ways to Minimize RiskFainting: Causes and Ways to Minimize Risk
Fainting: Causes and Ways to Minimize Risk
 
Vasovagal Syncope
Vasovagal SyncopeVasovagal Syncope
Vasovagal Syncope
 
Approach to Syncope
Approach to SyncopeApproach to Syncope
Approach to Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Syncope (Mary Collins)
Syncope (Mary Collins)Syncope (Mary Collins)
Syncope (Mary Collins)
 
Syncope
SyncopeSyncope
Syncope
 
Syncope assessement
Syncope assessementSyncope assessement
Syncope assessement
 
Aproach to syncope
Aproach to syncopeAproach to syncope
Aproach to syncope
 
Collapse and syncope
Collapse and syncopeCollapse and syncope
Collapse and syncope
 
Syncope
SyncopeSyncope
Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Syncope dr yate
Syncope  dr yateSyncope  dr yate
Syncope dr yate
 
Seminar syncope
Seminar  syncopeSeminar  syncope
Seminar syncope
 
Syncope
SyncopeSyncope
Syncope
 
Neurogenic Orthostatic Hypotension
Neurogenic Orthostatic Hypotension Neurogenic Orthostatic Hypotension
Neurogenic Orthostatic Hypotension
 
Syncope in pediatrics
Syncope in pediatricsSyncope in pediatrics
Syncope in pediatrics
 

Destacado (20)

Syncope
SyncopeSyncope
Syncope
 
Syncope
SyncopeSyncope
Syncope
 
Antibacterials 2
Antibacterials 2Antibacterials 2
Antibacterials 2
 
Cv arabic
Cv arabicCv arabic
Cv arabic
 
Dyslipidemia
DyslipidemiaDyslipidemia
Dyslipidemia
 
Dyslipidemia
DyslipidemiaDyslipidemia
Dyslipidemia
 
Current status & recent advances in dyslipidemia management
Current status & recent advances in dyslipidemia managementCurrent status & recent advances in dyslipidemia management
Current status & recent advances in dyslipidemia management
 
Dyslipidemia 2016
Dyslipidemia 2016Dyslipidemia 2016
Dyslipidemia 2016
 
Dyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approachDyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approach
 
Principles of Antimicrobial therapy _Pharmacology
Principles of Antimicrobial therapy_PharmacologyPrinciples of Antimicrobial therapy_Pharmacology
Principles of Antimicrobial therapy _Pharmacology
 
Dyslipidemia
DyslipidemiaDyslipidemia
Dyslipidemia
 
Infective endocarditis dr md toufiqur rahman nicvd cardiologist FAHA FACC
Infective endocarditis dr md toufiqur rahman nicvd cardiologist FAHA FACCInfective endocarditis dr md toufiqur rahman nicvd cardiologist FAHA FACC
Infective endocarditis dr md toufiqur rahman nicvd cardiologist FAHA FACC
 
Dyslipidemia guidelines
Dyslipidemia guidelinesDyslipidemia guidelines
Dyslipidemia guidelines
 
HYPOLIPIDEMIC DRUGS
HYPOLIPIDEMIC DRUGSHYPOLIPIDEMIC DRUGS
HYPOLIPIDEMIC DRUGS
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Hyperlipidemia
Hyperlipidemia Hyperlipidemia
Hyperlipidemia
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Dyslipidemia
DyslipidemiaDyslipidemia
Dyslipidemia
 
Hyperlipidemia and drug therapy for hyperlipidemia
Hyperlipidemia and drug therapy for hyperlipidemiaHyperlipidemia and drug therapy for hyperlipidemia
Hyperlipidemia and drug therapy for hyperlipidemia
 
Antihypertensives - drdhriti
Antihypertensives - drdhritiAntihypertensives - drdhriti
Antihypertensives - drdhriti
 

Similar a Syncope

Syncopeneurotalk2011 110718115506-phpapp01(1)
Syncopeneurotalk2011 110718115506-phpapp01(1)Syncopeneurotalk2011 110718115506-phpapp01(1)
Syncopeneurotalk2011 110718115506-phpapp01(1)Satya Chatterjee
 
3 Dizziness And Syncope. Karen Hauer, Md
3 Dizziness And Syncope. Karen Hauer, Md3 Dizziness And Syncope. Karen Hauer, Md
3 Dizziness And Syncope. Karen Hauer, MdMedicineAndHealth14
 
3 dizziness and syncope. karen hauer, md
3 dizziness and syncope. karen hauer, md3 dizziness and syncope. karen hauer, md
3 dizziness and syncope. karen hauer, mdAbdulmajid Abulsine
 
ECG Cap cuu (1).pptx
ECG Cap cuu (1).pptxECG Cap cuu (1).pptx
ECG Cap cuu (1).pptxHngVMinh5
 
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathySean M. Fox
 
Palpitations (dr. j dwight)
Palpitations (dr. j dwight)Palpitations (dr. j dwight)
Palpitations (dr. j dwight)Phchevalier
 
Non invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmiasNon invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmiasSunil Reddy D
 
03 Samir Rafla-Sudden Cardiac Death and Resuscitation.ppt
03 Samir Rafla-Sudden Cardiac Death and Resuscitation.ppt03 Samir Rafla-Sudden Cardiac Death and Resuscitation.ppt
03 Samir Rafla-Sudden Cardiac Death and Resuscitation.pptAlexandria University, Egypt
 
Acls mega code pdf
Acls mega code pdfAcls mega code pdf
Acls mega code pdfceipem
 
Acute coronary syndrome
Acute coronary syndrome Acute coronary syndrome
Acute coronary syndrome Dee Evardone
 
Approach to palpitation [autosaved]
Approach to palpitation [autosaved]Approach to palpitation [autosaved]
Approach to palpitation [autosaved]A.Salam Sharif
 
Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]Varsha Shah
 
Utility value of tilt table testing in evaluation
Utility value of tilt table testing in evaluationUtility value of tilt table testing in evaluation
Utility value of tilt table testing in evaluationUday Prashant
 

Similar a Syncope (20)

SYNCOPE..pptx
SYNCOPE..pptxSYNCOPE..pptx
SYNCOPE..pptx
 
Syncopeneurotalk2011 110718115506-phpapp01(1)
Syncopeneurotalk2011 110718115506-phpapp01(1)Syncopeneurotalk2011 110718115506-phpapp01(1)
Syncopeneurotalk2011 110718115506-phpapp01(1)
 
3 Dizziness And Syncope. Karen Hauer, Md
3 Dizziness And Syncope. Karen Hauer, Md3 Dizziness And Syncope. Karen Hauer, Md
3 Dizziness And Syncope. Karen Hauer, Md
 
3 dizziness and syncope. karen hauer, md
3 dizziness and syncope. karen hauer, md3 dizziness and syncope. karen hauer, md
3 dizziness and syncope. karen hauer, md
 
ECG Cap cuu (1).pptx
ECG Cap cuu (1).pptxECG Cap cuu (1).pptx
ECG Cap cuu (1).pptx
 
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
 
Arrythmias in ICCU
Arrythmias in ICCUArrythmias in ICCU
Arrythmias in ICCU
 
Mega Code
Mega CodeMega Code
Mega Code
 
Palpitations (dr. j dwight)
Palpitations (dr. j dwight)Palpitations (dr. j dwight)
Palpitations (dr. j dwight)
 
Non invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmiasNon invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmias
 
03 Samir Rafla-Sudden Cardiac Death and Resuscitation.ppt
03 Samir Rafla-Sudden Cardiac Death and Resuscitation.ppt03 Samir Rafla-Sudden Cardiac Death and Resuscitation.ppt
03 Samir Rafla-Sudden Cardiac Death and Resuscitation.ppt
 
Acls mega code pdf
Acls mega code pdfAcls mega code pdf
Acls mega code pdf
 
Dysautonomia
DysautonomiaDysautonomia
Dysautonomia
 
Acute coronary syndrome
Acute coronary syndrome Acute coronary syndrome
Acute coronary syndrome
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
Approach to palpitation [autosaved]
Approach to palpitation [autosaved]Approach to palpitation [autosaved]
Approach to palpitation [autosaved]
 
Allergic Myocardial Infarction
Allergic Myocardial InfarctionAllergic Myocardial Infarction
Allergic Myocardial Infarction
 
Evaluation of syncope in adults
Evaluation of syncope in adultsEvaluation of syncope in adults
Evaluation of syncope in adults
 
Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]Cardiology for g psaediatrics[1]
Cardiology for g psaediatrics[1]
 
Utility value of tilt table testing in evaluation
Utility value of tilt table testing in evaluationUtility value of tilt table testing in evaluation
Utility value of tilt table testing in evaluation
 

Más de Mohammed Alsheikh (14)

Curriculum vitae
Curriculum vitaeCurriculum vitae
Curriculum vitae
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Pericarditis
PericarditisPericarditis
Pericarditis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Obesity
ObesityObesity
Obesity
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Hocm
HocmHocm
Hocm
 
Ec gs for medical student
Ec gs  for medical studentEc gs  for medical student
Ec gs for medical student
 
Contrast nephropahthy
Contrast nephropahthyContrast nephropahthy
Contrast nephropahthy
 
Clopidogrel resistance
Clopidogrel resistanceClopidogrel resistance
Clopidogrel resistance
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Antibiotic choices
Antibiotic choicesAntibiotic choices
Antibiotic choices
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Anemiainelderly
AnemiainelderlyAnemiainelderly
Anemiainelderly
 

Syncope

  • 1. Syncope … The Right Test for the Right Patient (Osama Alhadramy MD, FRCP(C * Engel GL. 7th century
  • 2. Objectives  Who should be admitted?  Who should admit/see the patient in the ER ?(getting the right consult(  What is the right test for your patient?  Cases
  • 3. 76y M with high lipids ,HTN (HCT 4 /12(  Recurrent exersional syncope q 4 days for 2/12  Seen by GP , D/C HCT for postural hypotension without improvement .  Exersional SOB for 2 y class I-III  Nausea and Diarrhea for 2 weeks  Multiple injuries  O/E Obese , no CHF, no murmer
  • 4.
  • 5. 84 y M with no health issues  First episode witnessed syncope  Minimal CP on exertion for months  O/E B9, no murmurs  -ve CK / Trop
  • 6.
  • 7.
  • 8. ?Are we doing good job WHO** Statistical Information System**
  • 9. Definition  Syncope is a transient loss of consciousness, associated with loss of postural tone, with : 1. spontaneous return to baseline neurologic function 2. requiring no resuscitative efforts . *AHA/ACCF Scientific Statement on the Evaluation of Syncope J Am Coll Cardiol 2006;47:473– 84. *EHA statement 2004
  • 10. Impact of Syncope 100% 73% 1 71% 2 80% Proportion of Patients 60% 2 60% 37% 2 40% 20% 0% Anxiety/ Alter Daily Restricted Change Depression Activities Driving Employment Linzer, J Clin Epidemiol, 1991. 1 Linzer, J Gen Int Med, 1994. 2
  • 11. Syncope: Etiology Structural Non- Neurally- Cardiac Orthostatic Cardio- Cardio- Mediated Arrhythmia Pulmonary vascular 1 2 3 4 5 • Vasovagal • Drug • Brady • Aortic • Psychogenic • Carotid Induced Sick sinus Stenosis AV block • Metabolic Sinus • ANS • HOCM • Tachy e.g. hyper- • Situational Failure • Pulmonary Cough Primary VT* ventilation SVT Hypertension Post- Secondary • Long QT • PE micturition Syndrome Unknown Cause DG Benditt, UM Cardiac Arrhythmia Center
  • 13. Definitions EHA executive statement EHJ (2004( 25, 2054–2072
  • 14. Famous MCQ in medicine  …….. is the best tool to diagnose syncope and to determine the etiology . EPS History /Physical ILR HM Telemetry King's of Heart CT EEG
  • 15. How good is H/P 15 June 1997 • Annals of Internal Medicine
  • 17. Associated symptoms  Neurally-mediated syncope: 1. Absence of cardiac disease 2. Long history of syncope (Chronic presentation( 3. After unpleasant sight, sound, smell or pain 4. Prolonged standing or crowded, hot places 5. Nausea, vomiting associated with syncope 6. With head rotation, pressure on carotid sinus (as in tumors, shaving, tight collars(
  • 18. Syncope due to orthostatic hypotension: 1. After standing up 2. Temporal relationship with start of medication leading to hypotension or changes of dosage 3. Presence of autonomic neuropathy or Parkinsonism
  • 19. Things suggestive of seizure  Prodrome (aura)  Episode of abrupt onset associated with injury  Presence of a tonic phase before the onset of rhythmic clonic activity  Head deviation or unusual posturing during the episode  Tongue biting (particularly involving the lateral aspect of the tongue)  Loss of bladder or bowel control  Prolonged postictal phase during which the patient is confused and disoriented. .J Am Coll Cardiol 2002 Jul 3;40(1):142-8
  • 20. Are there predictors for ?cardiac syncope
  • 21. Predictors of cardiac syncope all comers Am J Med 2001 Aug 15;111(3(:177-84
  • 22. Predictors in patients with SHD JACC Vol. 37, No. 7, 2001 June 1,2001:1921– 8
  • 23. Patients without SHD JACC Vol. 37, No. 7, 2001 June 1, 2001:1921–8
  • 24. Absence of Pre-syncope  The sudden loss of consciousness without warning (pre-syncope( is most likely to result from an arrhythmia (bradycardia or tachycardia(.
  • 25. American Heart Journal 818 Krahn et al May 2001
  • 26. Duration of symptoms  A prolonged loss of consciousness may indicate a seizure or aortic stenosis.  By comparison, arrhythmias and neurocardiogenic syncope are often associated with a brief period of syncope, since the supine position reestablishes some blood flow to the brain and can therefore result in the restoration of consciousness
  • 27. Recovery  Persistence of nausea, pallor, and diaphoresis in addition to a prolonged recovery from the episode suggest a vagal event.  Significant neurologic changes or confusion during the recovery period may be due to a stroke or seizure.
  • 28. PHYSICAL EXAMINATION  Postural hypotension  Irregular heart beats : AF  Tachypnea : Massive PE  Murmur  CNS  Rectal exam
  • 29. work up  Carotid sinus massage  ECG  Holter Monitor  Implantable loop recorder  Echocardiography  Stress testing and angiogram  Electrophysiological study *ACC/AHA 2006
  • 30. Carotid sinus massage Class I in patients above the age of 40
  • 31. ECG  yield 2-10% *  Not classified but class I (my guidelines( * Kapoor, Am J Med, 1991.
  • 32. Telemetry  Class I 1. For patient with structural heart disease 2. High risk of life threatening arrhythmias.
  • 33. Holter monitor Yield 2-10% Holter Monitor 15 June 1997 • Annals of Internal Medicine
  • 34. Holter Monitor  Class I 1. patients who have the clinical or ECG features suggesting an arrhythmic cause of syncope. 2. Patients with very frequent syncopes
  • 35. ?Is one HM enough
  • 36. Series of 95 patients with syncope 1. 1st HM 14/95 (15%( 2. 2nd HM 9/ 81 (11%( 3. 3rd HM 3 /72 (4.2%( Arch Intern Med. 1990 May;150(5):1073-8
  • 37. Predictors of abnormal HM 1. age above 65 years 2. history of heart disease 3. initial none sinus rhythm Arch Intern Med. 1990 May;150(5):1073-8
  • 38. (Event recorders (King's of heart  Yield 20% *  often do not provide useful information since the patient must be conscious in order to activate the unit and "store" the rhythm at the time of the symptom . .Krahn, Cardiology Clinics, 1997*
  • 39. Implantable loop recorder  Yield 65-90% **  (ILR( is a subcutaneous monitoring device for the detection of cardiac arrhythmias.  It stores recorded ECG strips either when the device is activated automatically according to programmed criteria or when the patient manually activates it with magnet application Krahn, Circulation, 1995* Krahn, Cardiology Clinics, 1997*
  • 40. Insertable Loop Recorder Patient Activator Reveal® Plus ILR Programmer
  • 41. 56 y woman with syncope accompanied with seizures. AV Block 65 yo man with syncope. VT and VF
  • 42. RAST trial Unexplained Syncope n=60 ILR Conventional n=30 n=30 In Follow-up Diagnosed Undiagnosed Diagnosed Undiagnosed n=3 n=14 n=13 n=6 n=24 Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
  • 43. RAST Crossover Results Unexplained Syncope n=60 13/30 24/30 Undiagnosed after monitoring Undiagnosed after conventional 6 accepted crossover to conventional 21 accepted crossover to ILR Diagnosed Undiagnosed Diagnosed Undiagnosed In follow-up n=1 n=5 n=8 n=5 n=8 Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
  • 44. RAST - Diagnoses 14 12 number of patients 10 ILR Conventional 8 6 4 2 0 Bradycardia Tachycardia Vasovagal Seizures Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
  • 45. Class I 1. When the mechanism of syncope remains unclear after conventional work up. 2. Patients who have the clinical or ECG features suggesting an arrhythmic syncope 3. History of recurrent syncope with injury.
  • 46. Are there patients who do not need any cardiac ?monitor
  • 47. No need for any monitoring  Class III (ECG monitoring is unlikely to be useful( : 1. Do not have the clinical or ECG features suggesting an arrhythmic or structural heart disease 2. No recurrent syncope( single episode(
  • 48. Can they exclude cardiac causes of ?syncope
  • 49. Class I ECG monitoring excludes an arrhythmic cause when there is a correlation between syncope and no rhythm variation
  • 50. Echocardiography  Diagnoses of underlying structural heart disease such as left ventricular dysfunction, hypertrophic cardiomyopathy, or significant aortic stenosis .  Yield 0-20%
  • 52. CONCLUSIONS:  Echocardiography was most useful for assessing the severity of the underlying cardiac disease and for risk stratification in patients with unexplained syncope but with a positive cardiac history or an abnormal ECG
  • 53. Class I  ECHO is recommended if suspect structural or coronary heart disease.
  • 54. Upright tilt table test  Very useful in young, and healthy patients in whom the diagnosis of neurocardiogenic syncope is suspected .  Yield 11-90% *** *PACE, Vol. 20 April 1997, Part I 875 *Kapoor, JAMA, 1992
  • 55. Diagnosing VVS (ACC Consensus Protocol(  Overnight fast  ECG  Blood pressure  Supine least 5 -20 min  Tilt minimum of 20 min and a 60° 80° maximum of 45 min
  • 56. PACE, Vol. 20 April 1997, Part I 875
  • 57. Class I 1. Unexplained single syncopal episodes in high risk settings 2. Recurrent episodes in the absence of organic heart disease 3. In the presence of organic heart disease, after cardiac causes of syncope have been excluded.
  • 58. Coronary angiogram / stress testing  Class I 1. In patients with syncope suspected to be due to myocardial ischemia. 2. Patients with syncope and risk factors for CAD and symptoms of angina or angina equivalent. 3. Syncope related to exersice
  • 59. Electrophysiology study  Patients who may benefit from an EP study include those with: 1. Left ventricular dysfunction 2. Significant coronary artery disease 3. A prior myocardial infarction 4. Other structural heart disease 5. Conduction system disease (eg, bundle branch block(  Yield 50% Stetson P, et al. PACE. 1999; 22 (part II): 782
  • 60. Class I 1. Abnormal electrocardiography 2. Structural heart disease 3. syncope associated with palpitations or family history of sudden death
  • 61. Can EPS role out cardiac causes of ??syncope
  • 62. Class I Normal electrophysiological findings can not completely exclude an arrhythmic cause of syncope.
  • 63. ?What to do then
  • 64. :Further work up (ILR (preferred HM King's of heart
  • 65. BNP 148 patients with syncope THE AMERICAN JOURNAL OF CARDIOLOGY VOL. 93 JANUARY 15, 2004
  • 66. ?Who should be admitted  Abnormal ECG  History of cardiac disease, chest pain or heart failure  Persistently low blood pressure (systolic <90 mmHg(  Exersional SOB or angina  Hematocrit <30 (if obtained(  Older age >60  Family history of sudden cardiac death Ann Emerg Med. 2007 Apr;49(4):431-44 Am J Emerg Med. 2005 Oct;23(6):782-6
  • 68. Prognosis N Engl J Med, Vol. 347, No. 12 September 19, 2002
  • 70. Conventional Diagnostic Methods/Yield Test/Procedure Yield History and Physical 49-85% 1, 2 (including carotid sinus massage( ECG 2-11% 2 Electrophysiology Study without SHD* 11% 3 Electrophysiology Study with SHD 49% 3 Tilt Table Test (without SHD) 11-87% 4, 5 Ambulatory ECG Monitors: • Holter 2% 7 • External Loop Recorder 20% 7 (2-3 weeks duration( • Insertable Loop Recorder 65-88% 6, 7 (up to 14 months duration( Neurological † (Head CT Scan, Carotid Doppler( 0-4% 4,5,8,9,10 1 Kapoor, et al N Eng J Med, 1983. 5 Kapoor, JAMA, 1992 9 Day S, et al. Am J Med. 1982; 73: 15-23. 2 Kapoor, Am J Med, 1991. 6 Krahn, Circulation, 1995 10 Stetson P, et al. PACE. 1999; 22 (part II(: 782. * Structural Heart Disease 3 Linzer, et al. Ann Int. Med, 1997. 7 Krahn, Cardiology Clinics, 1997. 8 Eagle K,, et al. The Yale J Biol and Medicine. 1983; 56: 1-8. † MRI not studied 4 Kapoor, Medicine, 1990.
  • 71. Bottom line  In young patients without suspicion of heart or neurological disease and recurrent syncope , tilt testing should be done first.  Older patients, carotid sinus massage is recommended as first step.  Patients with evidence of structural heart disease from H&P , palpitation, extensional symptoms cardiac work up should be done first .
  • 72. ..Back to the cases
  • 73. 76y M with high lipids ,HTN (HCT 4 /12(  Recurrent syncope q 4 days for 2/12  Seen by GP , D/C HCT for postural hypotension without improvement .  Exersional SOB for 2 y class II  Nausea and Diarrhea for 2 weeks  Multiple injuries  O/E Obese , no CHF, no murmer
  • 74.
  • 75. Telemetry : no arrhythmia  ECHO:EF 40% with segmental RWMA, mild AV sclerosis  MIBI: High risk Circ ischemia , EF 45%
  • 76.
  • 77. 84 y M with no health issues  First episode witnessed syncope  Minimal CP on exertion for months  O/E B9, no murmurs  -ve CK / Trop
  • 78.
  • 79. EP : Pace maker  ECHO: EF 45-50% with DD  D/C home  10 days later came with syncope / fall  New ant T changes with Trop 23 , no CP
  • 80.

Notas del editor

  1. Impact of Syncope Syncope result in substantial cost to patients and to society. For example, syncope patients live with lifestyle altering restrictions that affect daily activities, mobility, and employment. In addition, syncope and falling in the elderly commonly cause injury, institutionalization and premature death. Falls directly or indirectly cause 12% of deaths in geriatric population. (Baraff 1997 ). ____________________ Linzer M, Pontinen M, Gold DT, et al. Impairment of physical and psychological function in recurrent syncope. J Clin Epidemiol. 1991;44:1037-1043 . Linzer M, Gold DT, Pontinen M, et al. Recurrent syncope as a chronic disease: Preliminary validation of a disease-specific measure of functional impairment. J Gen Int Med. 1994;9:181-186 .
  2. This slide provides a simple classification of the principal causes of syncope. This scheme lists the causes of syncope from the most commonly observed (Left) to the least common (Right). This ranking may be helpful in thinking about the strategy for evaluating syncope in individual patients . Within the boxes,the most common causes of syncope are indicated for each of the major diagnostic groups. The numbers at the bottom of each column provide an approximate value for the average frequency (Kapoor 1998) with which that category appears in published reports summarizing diagnostic findings. It should be noted that orthostatic causes are not often referred to specialists and consequently tend to be under represented in the literature .
  3. The Reveal ® Plus Insertable Loop Recorder system offers long-term, continuous, subcutaneous ECG monitoring and event-specific recording. This implantable device is designed to improve patient compliance with long-term AECG monitoring . The system includes an implanted loop recorder, a hand-held patient Activator, and a programmer with telemetry head that communicates noninvasively with the implanted device . When a patient experiences an episode, the device stores an ECG using the Activator or through the use of a auto-activating feature . The Reveal ® Plus ILR can monitor continuously for up to 14 months. The probability of capturing an event is high—approximately 65-88%. 1,2 The ECG captured during the episode may “reveal” the ECG during the patient’s episode or may allow the clinician to rule in or rule out arrhythmic causes . The stored ECG data is retrieved, viewed, and printed or saved to a disk, using a Medtronic 9790 programmer with a 9766 A or AL programmer head . The Reveal ILR can then be re-started for continued monitoring . 1 . Krahn A, et al. Final results from a pilot study with an insertable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol, 1998;82:117-119 . 2 . Krahn A, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial. Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51
  4. Examples of ECG recordings obtained by the Reveal® ILR system in 2 symptomatic patients. See associated text for details .
  5. Results of the initial phase of RAST are summarized here. Among patients randomized to ILR, there appeared to be greater diagnostic yield than in patients randomized to the conventional diagnostic pathway .
  6. In RAST, patients who remained undiagnosed after completion of the first arm of the study (see preceding slide) were offered crossover to the other diagnostic strategy arm. Once again, ILR proved superior to the conventional diagnostic strategy
  7. Results show patients implanted with the ILR are more likely to receive a diagnosis in any category . The ILR was almost 5 times better at detecting bradycardia compared to conventional testing . Reference Krahn A, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial. Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51
  8. Diagnosing VVS VVS is most effectively diagnosed if the detailed medical history is ‘classic’. However, this is not often the case, and supporting evidence is needed, Such supportive evidence may include : Patient history, physical examination, ECG, and other tests provide no diagnosis for patient complaints of syncope . Patient experiences syncope during head-up tilt table testing. Test completion without syncope is a negative result . The following HUT protocol is based on the ACC Consensus Document on tilt table testing (Benditt 1996). Other accepted HUT protocols do exist . Overnight fast, morning test ECG (at least 3 leads ) Continuous blood pressure monitoring Patient remains supine on the table for 15-30 minutes . Tilt to 60-80 degrees for 20-45 minutes . Lower to horizontal and administer isoproterenol at 1-5  g/min until heart rate increases 25% . Re-tilt for 10 minutes REFERENCE : Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for syncope. ACC Expert Consensus Document. JACC. 1996;28(1):263-275 .
  9. A yield is defined as information that will point to more finely focused tests, specialties, or treatments . Patient history and physical exam are the most productive diagnostic tools for recurrent syncope, accounting for 49-85% of all syncope diagnoses. 1,2 An ECG, also considered a first-line test, is diagnostic in 2-11% of cases. 2 Beyond that, other tests have variable diagnostic yields. Holter monitors (worn for 1-3 days) capture ECGs during a syncopal episode in only 1% of patients, based on a mean time to recurrent event of 5.1 months. 7 The effectiveness of tilt table tests, a common tool used to identify vasovagal syncope, depends on several factors, including patient selection and use of provocative drugs. Depending on these factors, the rate of positive tests has been reported in the range of 11-87%. 3,5 However, about 10% or more of the population (who do not experience syncope) will have positive tilt table tests. 4,6 External loop recorders (worn for 2-3 weeks) are most productive in motivated patients who experience relatively frequent syncope. They provide a diagnostic yield of 20%. 7 Electrophysiology (EP) studies are generally more productive in patients with structural heart disease (SHD) and therefore are generally a higher priority for patients in this group. 1 EP studies are used to diagnose syncope by inducing symptoms under controlled conditions, thereby attaining a “presumptive” diagnosis. 1 EP testing usually fails to identify intermittent bradycardia as a cause of syncope (6%) and may sometimes reveal unrelated rhythm disturbances that may be mistakenly identified as the cause of syncope. 2 1 . Kapoor W, et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204 . 2 . Kapoor W. Diagnostic evaluation of syncope. Amer J Med 1991;90:91-106 . 3 . Linzer M, et al. Clinical guideline: Diagnosing syncope: Part 2: Unexplained syncope. Ann Intern Med 1997;127:76-86 . 4 . Kapoor W. Evaluation and outcome of patients with syncope. Medicine 1990;69:160-175 . 5 . Kapoor W. Evaluation and management of the patient with syncope. JAMA 1992;268:2553-2560 . 6 . Krahn A, et al. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation 1995;92:1819-1824 . Krahn A, Klein G, Yee R: Recurrent syncope. Experience with an implantable loop recorder. Cardiology Clinics 1997; 15(2):313-326 . 8 . Eagle K,, et al. The Yale J Biol and Medicine. 1983; 56: 1-8 . 9 . Day S, et al. Am J Med. 1982; 73: 15-23 . 10 . Stetson P, et al. PACE. 1999; 22 (part II): 782 . Please also see : Brignole M, Alboni P, Benditt DG, et al. “Guidelines on Management (Diagnosis and Treatment) of Syncope. Eur Heart Journal 2001; 22: 1256-1306 .